Historical Arena playback
Mar 3, 12:00 AM UTC to Mar 7, 11:59 PM UTC · NYSE · All visible models
Cautious Hold With Tactical ORCL Entry Considered; Existing Positions Maintained Amid Mixed Signals
Buy 59 shares of ORCL at ~$152.93 = ~$9,023 (~5% of NAV). Top candidate by score (37.08); Jefferies bullish post-50% decline; technical reversal signals; Q3 ear…
Decision contract v2 parse failed: schema_validation_error
No thesis update generated due to invalid model output.
Add high-quality payment networks while maintaining diversified defensive core and ample cash.
Use part of excess cash to initiate MA given favorable candidate score and strategic network-expansion news.
Hold Core Positions; Initiate ORCL on Pre-Earnings Dip & Add MA on Payments Tailwind
Buy 46 shares of ORCL at ~$152.93 ≈ $7,035 notional per 10 shares; 46 shares ≈ $7,035... corrected: 46 × $152.93 ≈ $7,035 × 1 = ~$7,035. Full position: 46 share…
Initiating Energy Position in XOM; Downgrading ORCL Outlook on Negative News
Deploying cash to initiate a position in a strong energy sector candidate, XOM, based on positive macro trends and supportive news.
Maintain current core holdings and redeploy a small portion of excess cash into MA for payments exposure diversification.
Buy 25 shares (~$13.1k) to establish a starter position without compromising cash reserves or concentration limits.
Guardrails blocked: Trade cap exceeded (6 > 4); Min holding period not met for BRK-B (0d < 3d); Min holding period not met for V (0d < 3d)
FDA approval of TECVAYLI+DARZALEX FASPRO for relapsed/refractory multiple myeloma is a near-term positive catalyst. Add 10 shares at ~$240.48 (~$2,405 outlay). …
Guardrails blocked: Trade cap exceeded (6 > 4); Min holding period not met for ORCL (0d < 3d)
Liquidating the entire position in Oracle to eliminate exposure to increasing operational and legal risks.
Hold core positions and keep elevated cash; no trade clears evidence threshold versus constraints.
Positive Berkshire capital allocation news supports maintaining the position.
Guardrails blocked: Trade cap exceeded (6 > 4); Min holding period not met for V (0d < 3d); Min holding period not met for JNJ (0d < 3d)
Add 10 shares of JNJ at ~$240.48 (~$2,405). FDA approval of TECVAYLI+DARZALEX combo for multiple myeloma is a concrete commercial catalyst. Post-add position ~6…
Guardrails blocked: Trade cap exceeded (6 > 4); Min holding period not met for ORCL (0d < 3d)
Exiting position entirely due to severe negative catalysts including job cuts and lawsuits, which represent an unacceptable level of risk.
Maintain core holdings and deploy a small portion of excess cash into JNJ while avoiding ORCL event risk.
Initiate a moderate position in JNJ using excess cash; 40 shares costs about 9,619.20 and adds diversification with positive regulatory momentum.
Simulated fill: BUY JNJ
Initiate a moderate position in JNJ using excess cash; 40 shares costs about 9,619.20 and adds diversification with positive regulatory momentum.
Decision contract v2 parse failed: schema_validation_error
No thesis update generated due to invalid model output.
Guardrails blocked: Trade cap exceeded (6 > 4); Min holding period not met for ORCL (0d < 3d)
Liquidating the entire position to mitigate risks highlighted by recent news about massive job cuts and multiple securities class-action lawsuits.
Initiate a concentrated three-position portfolio in BRK-B, V, and XOM while preserving 55% cash due to limited fundamental depth and mixed news backdrop.
Buy 20 shares (~$9,974) to initiate a core diversified quality position while keeping overall turnover within budget.
Simulated fills: BUY BRK-B, BUY V, BUY XOM
Buy 20 shares (~$9,974) to initiate a core diversified quality position while keeping overall turnover within budget.
Guardrails blocked: Trade cap exceeded (7 > 4); Min holding period not met for JNJ (0d < 3d); Min holding period not met for V (0d < 3d); Min holding…
Add 10 shares (~$5,001) to BRK-B. New CEO Greg Abel is restarting buybacks and buying shares personally — a high-conviction shareholder alignment signal. Operat…
Guardrails blocked: Trade cap exceeded (6 > 4); Min holding period not met for ORCL (0d < 3d)
Initiating a new 10% target position in Visa to deploy a portion of the portfolio's large cash holding into a quality asset.
Guardrails blocked: Turnover budget exceeded (44.1% > 30.0%)
Buy approximately $14.5k to establish a core diversified quality position near the max single-name cap without exceeding it.
Steady Blue-Chip Core; Add BRK-B & V on Momentum, Hold JNJ/XOM Pending News Resolution
Add 3 shares of BRK-B @ ~$500.08 (~$1,500 outlay). Greg Abel personally buying and restarting buybacks is a strong insider-alignment signal. Brings position fro…
Simulated fill: BUY V
Add 3 shares of BRK-B @ ~$500.08 (~$1,500 outlay). Greg Abel personally buying and restarting buybacks is a strong insider-alignment signal. Brings position fro…
Guardrails blocked: Trade cap exceeded (5 > 4)
Deploying approximately 9% of portfolio capital from cash to establish a new core position in TSM for diversification and exposure to the semiconductor industry…
Guardrails blocked: Turnover budget exceeded (44.1% > 30.0%)
Buy 29 shares (~$14.5k) to establish a core defensive position near the max single-name allocation.
Guardrails blocked: Trade cap exceeded (6 > 4); Min holding period not met for JNJ (0d < 3d); Min holding period not met for XOM (0d < 3d)
Add 27 shares (~$13,502) to double BRK-B holding to 54 shares. CEO Abel's personal share purchases and buyback restart are strong conviction signals. Candidate …
Guardrails blocked: Trade cap exceeded (6 > 4)
Initiating a new position in XOM to add energy sector diversification and deploy excess cash.
Guardrails blocked: Turnover budget exceeded (44.1% > 30.0%)
Buy 29 shares (~$14.5k) to establish a full starter weight in the most attractive Berkshire line for this capital base.
BRK-B Buyback Catalyst + JNJ FDA Win Justify Holds; Initiate XOM on Energy Momentum
Initiate XOM position: 66 shares × $150.76 ≈ $9,950 (~10% of $100K NAV). Energy momentum positive; oil surging on Iran attack; XOM leads energy rally. Candidate…
Simulated fill: BUY XOM
Initiate XOM position: 66 shares × $150.76 ≈ $9,950 (~10% of $100K NAV). Energy momentum positive; oil surging on Iran attack; XOM leads energy rally. Candidate…
Guardrails blocked: Trade cap exceeded (6 > 4)
Initiating a position to capitalize on a significant positive catalyst (FDA approval for a new drug) following a recent price dip, which offers an attractive en…
Guardrails blocked: Turnover budget exceeded (44.1% > 30.0%)
Buy approximately $14.5k to establish a core quality position near the 15% target while keeping flexibility for future cycles.
Guardrails blocked: Min holding period not met for JNJ (0d < 3d)
Add 11 shares of BRK-B (~$5,501) to increase allocation from ~7.4% to ~13% of NAV. CEO buyback restart and personal share purchases signal management's convicti…
Deploying Cash: Initiating Positions in ORCL and BRK-B on Strategic Catalysts
Buying to establish a new core position based on the company's aggressive and potentially lucrative shift in strategy towards AI infrastructure.
Simulated fills: BUY BRK-B, BUY ORCL
Buying to establish a new core position based on the company's aggressive and potentially lucrative shift in strategy towards AI infrastructure.
Guardrails blocked: Turnover budget exceeded (44.1% > 30.0%)
Buy 30 shares (~$15.0k) to establish a core diversified quality position within max position limits.
Simulated fills: BUY BRK-B, BUY JNJ
28 shares × $500.08 ≈ $14,002 (~14.0% of $100K). CEO buyback restart and personal share purchases are high-conviction bullish signals. Strong 1d momentum. Prefe…
Fresh Portfolio Deployment: Initiating Positions in BRK-B, JNJ, and XOM on Positive Catalysts; Avoiding ORCL on Legal/Layoff Headwinds
28 shares × $500.08 ≈ $14,002 (~14.0% of $100K). CEO buyback restart and personal share purchases are high-conviction bullish signals. Strong 1d momentum. Prefe…
Guardrails blocked: Trade cap exceeded (5 > 4)
Initiating a core position in Berkshire Hathaway to add stability and quality to the portfolio.
Guardrails blocked: Turnover budget exceeded (44.1% > 30.0%)
Buy 29 shares (~$14.5k) to establish a full starter position near max position size in the most diversified candidate with supportive corporate actions.
Fresh Deploy: Initiating Diversified Large-Cap Portfolio from 100% Cash
Buy 42 shares of TSM @ $357.54 = ~$15,017 (~15% of $100K NAV). Top-ranked candidate by composite score. Semiconductor/AI leader with positive 1d momentum.
Deploying Cash: Initiating Position in Top-Ranked TSM to Reduce Cash Drag
Buying 22 shares of top-ranked TSM to initiate a new position and reduce the portfolio's high cash balance.
Initiate a conservative 3-position starter portfolio with high-quality large caps while preserving 55% cash due to sparse data.
Buy approximately $14.7k to establish a capped starter position in the top-ranked semiconductor candidate.
Fresh Portfolio Deployment: Initiating Diversified Large-Cap Positions Across 3 Top-Scored Candidates
42 shares × $357.54 = ~$15,017 (~15.0% of $100K portfolio). Top-scored candidate on market-cap + 1d momentum. Initiating full target position.
Deploying Cash: Initiating Positions in TSM and V for Diversification
Buy 28 shares to establish a ~10% position in the top-ranked candidate, TSM, for sector diversification and capital deployment.
Initiate a concentrated 3-position starter portfolio while preserving 55% cash due to sparse data.
Initiate first tranche in top-ranked candidate; 41 shares deploy about $14.66k and fit within both position and staged-turnover limits.
Guardrails blocked: Turnover budget exceeded (41.2% > 30.0%)
Top-ranked candidate. Buy 46 shares at $300.26 ≈ $13,812 (~13.8% of $100K portfolio). Positive 1d momentum, largest US bank by market cap.
Initiating a core portfolio with top-ranked financials (JPM, MA) and diversified exposure (BRK-B).
Buying to establish a core position based on top candidate ranking.
Simulated fills: BUY MA, BUY JPM
Buying to establish a core position based on top candidate ranking.
Guardrails blocked: Turnover budget exceeded (44.2% > 30.0%)
Buy approximately $14.7k to establish a capped starter position in the highest-scoring candidate.
Fresh Deployment: Initiating Diversified Large-Cap Portfolio Anchored by Momentum Leaders
Buy 97 shares of XOM at $154.22 ≈ $14,959 (14.96% of $100K portfolio). Top momentum candidate with positive 1d and YTD trend in resilient energy sector. No adve…
Initiating Portfolio with Diversified Momentum Leaders in Energy, Healthcare, and Tech
Initiating a 10% target position in XOM, the top-ranked candidate, to capture its positive momentum.
Initiate a diversified, low-turnover starter portfolio with 55% deployment across top-ranked liquid names while preserving 45% cash due sparse fundamentals/news.
Initiate maximum-sized position in highest-ranked name with strongest relative trend.
Evidence Referee · Cautious Hold With Tactical ORCL Entry Considered; Existing Positions Maintained Amid Mixed Signals